Publications by the researcher in collaboration with ESTHER GONZÁLEZ MONTE (35)

2026

  1. Diagnostic Performance of Two Different Techniques to Quantify CMV-Specific Cell-Mediated Immunity in Intermediate-Risk Seropositive Kidney Transplant Recipients

    Transplant Infectious Disease, Vol. 28, Núm. 1

  2. Evaluation of an Immune-guided Prevention Strategy Against CMV Among Intermediate-risk Kidney Transplant Recipients: A Quasi-experimental Study

    Transplantation, Vol. 110, Núm. 6, pp. e1265-e1275

  3. Infectious Complications in Living Donation Versus Donation After Brain Death Kidney Transplantation

    Transplant Infectious Disease

2025

  1. CTLA4 Single-Nucleotide Polymorphisms Influence the Risk of HSV and VZV Infection in Kidney Transplant Recipients: A Prospective Cohort Study

    Transplant International, Vol. 38

  2. Human Cytomegalovirus Infection Induces Long-Term Changes in the Cytokine Milieu of Kidney Transplant Recipients

    Journal of Medical Virology, Vol. 97, Núm. 1

  3. Infection Risk in Older Kidney Transplant Recipients: An Analysis in the Era of Expanded Age Limits

    Transplant International, Vol. 38

  4. Knowledge and Adherence to Lifestyle Habits to Prevent Complications Associated With Immunosuppression in Kidney Transplant Recipients: A Single-Center Survey

    Transplant Infectious Disease, Vol. 27, Núm. 4

2024

  1. Dynamics and Clinical Significance of Cytomegalovirus-Specific Neutralizing Antibodies in Kidney Transplant Recipients Treated with T-Cell–Depleting Agents

    Journal of Infectious Diseases, Vol. 229, Núm. 6, pp. 1812-1816

  2. Human microRNA sequencing and cytomegalovirus infection risk after kidney transplantation

    American Journal of Transplantation, Vol. 24, Núm. 7, pp. 1180-1192

  3. Performance of a Global Functional Assay Based on Interferon-γ Release to Predict Infectious Complications and Cancer After Kidney Transplantation

    Transplant International, Vol. 37

2023

  1. A joint program of antimicrobial stewardship and hospital-acquired infection control to reduce healthcare-associated infections after kidney transplantation: The Hipomenes study

    American Journal of Transplantation, Vol. 23, Núm. 12, pp. 1949-1960

2022

  1. Fluconazole versus micafungin for initial antifungal prophylaxis against Candida in pancreas transplant recipients: A comparative study of two consecutive periods

    Mycoses, Vol. 65, Núm. 5, pp. 517-525

  2. Genetic polymorphisms in TLR3, IL10 and CD209 influence the risk of BK polyomavirus infection after kidney transplantation

    Scientific Reports, Vol. 12, Núm. 1

  3. Human pegivirus type 1 infection in kidney transplant recipients: Replication kinetics and clinical correlates

    Transplant Infectious Disease, Vol. 24, Núm. 1

  4. Impact of polymorphisms in genes orchestrating innate immune responses on replication kinetics of Torque teno virus after kidney transplantation

    Frontiers in Genetics, Vol. 13

  5. Influence of single-nucleotide polymorphisms in TLR3 (rs3775291) and TLR9 (rs352139) on the risk of CMV infection in kidney transplant recipients

    Frontiers in Immunology, Vol. 13

2021

  1. CMV infection, valganciclovir exposure, and the risk of BK viremia and associated nephropathy after kidney transplantation: Is there a link?

    Transplant Infectious Disease, Vol. 23, Núm. 4

2020

  1. COVID-19 in solid organ transplant recipients: A single-center case series from Spain

    American Journal of Transplantation, Vol. 20, Núm. 7, pp. 1849-1858

  2. Derivation and external validation of the SIMPLICITY score as a simple immune-based risk score to predict infection in kidney transplant recipients

    Kidney International, Vol. 98, Núm. 4, pp. 1031-1043

  3. Monitoring of CMV-specific cell-mediated immunity with a commercial ELISA-based interferon-γ release assay in kidney transplant recipients treated with antithymocyte globulin

    American Journal of Transplantation, Vol. 20, Núm. 8, pp. 2070-2080